Loading...
MTAAREC
Market cap10bUSD
Dec 20, Last price  
50.40EUR
1D
0.10%
1Q
0.92%
Jan 2017
87.22%
Name

Recordati Industria Chimica e Farmaceutica SpA

Chart & Performance

D1W1MN
MTAA:REC chart
P/E
26.59
P/S
4.97
EPS
1.90
Div Yield, %
2.38%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
9.02%
Revenues
2.08b
+12.36%
488,308,000576,080,000576,186,000628,435,000689,634,000747,524,000728,134,000762,036,000828,317,000941,630,000987,356,0001,047,676,0001,153,942,0001,288,123,0001,352,235,0001,481,848,0001,448,867,0001,580,074,0001,853,307,0002,082,331,000
Net income
389m
+24.61%
53,964,00064,543,00074,031,00084,865,000100,429,000110,566,000108,580,000116,446,000118,484,000133,678,000161,187,000198,792,000237,406,000288,762,000312,376,000368,825,000354,984,000385,966,000312,336,000389,214,000
CFO
485m
+5.12%
96,895,00083,061,00096,594,00091,820,000147,616,000155,019,000140,575,000121,460,000112,752,000170,119,000179,155,000247,372,000255,436,000272,711,000371,577,000334,027,000403,575,000491,650,000461,691,000485,319,000
Dividend
May 20, 20240.63 EUR/sh
Earnings
Feb 20, 2025

Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
URL
https://www.recordati.it/
IPO date
Jan 01, 1984
Employees
4,300
Domiciled in
IT
Incorporated in
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,082,331
12.36%
1,853,307
17.29%
1,580,074
9.06%
Cost of revenue
1,516,564
1,358,997
1,074,754
Unusual Expense (Income)
NOPBT
565,767
494,310
505,320
NOPBT Margin
27.17%
26.67%
31.98%
Operating Taxes
101,822
89,099
77,383
Tax Rate
18.00%
18.02%
15.31%
NOPAT
463,945
405,211
427,937
Net income
389,214
24.61%
312,336
-19.08%
385,966
8.73%
Dividends
(245,958)
(230,602)
(216,742)
Dividend yield
2.41%
2.85%
1.83%
Proceeds from repurchase of equity
7,387
(38,619)
(59,308)
BB yield
-0.07%
0.48%
0.50%
Debt
Debt current
110,181
374,971
231,718
Long-term debt
1,380,853
1,363,120
775,564
Deferred revenue
Other long-term liabilities
21,239
19,418
21,010
Net debt
1,247,667
1,424,486
728,580
Cash flow
Cash from operating activities
485,319
461,691
491,650
CAPEX
(29,687)
(96,339)
(87,360)
Cash from investing activities
(379,618)
(767,124)
(87,499)
Cash from financing activities
(168,914)
341,277
(355,943)
FCF
642,409
235,392
508,320
Balance
Cash
221,812
284,734
244,578
Long term investments
21,555
28,871
34,124
Excess cash
139,250
220,940
199,698
Stockholders' equity
2,051,806
1,862,576
1,688,069
Invested Capital
3,031,778
3,027,631
2,165,585
ROIC
15.31%
15.61%
19.68%
ROCE
17.07%
14.47%
21.13%
EV
Common stock shares outstanding
209,142
209,060
209,082
Price
48.83
26.01%
38.75
-31.42%
56.50
24.64%
Market cap
10,212,423
26.06%
8,101,084
-31.42%
11,813,152
24.65%
EV
11,460,090
9,663,079
12,695,985
EBITDA
708,437
620,066
602,905
EV/EBITDA
16.18
15.58
21.06
Interest
74,455
32,158
17,420
Interest/NOPBT
13.16%
6.51%
3.45%